{
    "clinical_study": {
        "@rank": "168263", 
        "acronym": "TAPAS", 
        "arm_group": {
            "arm_group_label": "Acromegalic patients", 
            "description": "Acromegalic subjects treated with Somatuline Autogel\u00ae (Lanreotide)"
        }, 
        "brief_summary": {
            "textblock": "This is a long term study to evaluate common therapeutic algorithms and possible predictive\n      parameters for Somatuline Autogel treatment in patients with Acromegaly."
        }, 
        "brief_title": "Predictive Factors Study", 
        "completion_date": {
            "#text": "February 2020", 
            "@type": "Anticipated"
        }, 
        "condition": "Acromegaly", 
        "condition_browse": {
            "mesh_term": "Acromegaly"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of Acromegaly.\n\n          -  Males and females aged 18 years and older.\n\n          -  Signed informed consent (patient must give consent to the collection of retrospective\n             data).\n\n          -  Patients who have had surgery may enter the study 3 months post-surgery and evaluated\n             for the duration of the study.\n\n          -  With the intention to be treated with ATG (decision to prescribe ATG made prior to\n             inclusion into the study) or already being treated with ATG.\n\n          -  If already being treated with ATG:\n\n        Previous ATG treatment maximum of 3 months.  AND Minimum data available (demographic data,\n        disease history including previous treatments, GH, IGF-1 levels at baseline and under\n        treatment as applicable).\n\n          -  Not receiving Dopamine Agonists or other medical therapy (Pegvisomant, or other\n             somatostatin analogues) for the treatment or symptom control of acromegaly.\n\n        Exclusion Criteria:\n\n          -  The subject has had radiotherapy in the last 5 years.\n\n          -  The subject has had surgery in the last 3 months.\n\n          -  The subject has already been included in this study.\n\n          -  Participation in an interventional trial, or receiving experimental drug."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Adult subjects in hospitals and private practices, suffering from acromegaly who are\n        scheduled to receive ATG or already on treatment with ATG for a maximum of 3 months."
            }
        }, 
        "enrollment": {
            "#text": "34", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02020499", 
            "org_study_id": "A-9B-52030-265"
        }, 
        "intervention": {
            "arm_group_label": "Acromegalic patients", 
            "description": "Patients receiving treatment as prescribed by the investigator and according to current treatment recommendations and routine clinical practice, and in line with local regulations.", 
            "intervention_name": "Somatuline Autogel\u00ae (lanreotide) 60, 90, 120 mg.", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Lanreotide", 
                "Angiopeptin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 29, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Darlinghurst", 
                        "country": "Australia", 
                        "state": "New South Wales", 
                        "zip": "2010"
                    }, 
                    "name": "St Vincent's Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St Leonards", 
                        "country": "Australia", 
                        "state": "New South Wales", 
                        "zip": "2065"
                    }, 
                    "name": "Royal North Shore Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Herston", 
                        "country": "Australia", 
                        "state": "Queensland", 
                        "zip": "4006"
                    }, 
                    "name": "Royal Brisbane & Women's Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Woolloongabba", 
                        "country": "Australia", 
                        "state": "Queensland", 
                        "zip": "4102"
                    }, 
                    "name": "Princess Alexandra Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fitzroy", 
                        "country": "Australia", 
                        "state": "Victoria", 
                        "zip": "3065"
                    }, 
                    "name": "St Vincent's Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Heidelberg", 
                        "country": "Australia", 
                        "state": "Victoria", 
                        "zip": "3084"
                    }, 
                    "name": "The Austin Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nedlands", 
                        "country": "Australia", 
                        "state": "Western Australia", 
                        "zip": "6009"
                    }, 
                    "name": "Sir Charles Gairdner Hospital"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Australia"
        }, 
        "number_of_groups": "1", 
        "official_title": "Non-interventional, Observational, Long Term Study to Evaluate Common Therapeutic Algorithms and Possible Predictive Parameters for Somatuline Autogel (ATG) Treatment in Patients With Acromegaly.", 
        "overall_contact": {
            "email": "clinical.trials@ipsen.com", 
            "last_name": "Ipsen Recruitment Enquiries"
        }, 
        "overall_official": {
            "affiliation": "Ipsen", 
            "last_name": "M\u00f3nica De Abadal, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Australia: Department of Health and Ageing Therapeutic Goods Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in Growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels from baseline", 
            "safety_issue": "No", 
            "time_frame": "Baseline and 4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02020499"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Change in Growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels from baseline", 
            "safety_issue": "No", 
            "time_frame": "Baseline, 1 year and 3 years"
        }, 
        "source": "Ipsen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ipsen", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}